Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening
Wei JiniD, Yexuan Deng, John E. La MarcaiD, Emily J. LelliottiD, Sarah T. DiepstrateniD, Christina KoenigiD, Lin TaiiD, Valentina SnetkovaiD, Kristel M. DorighiiD, Luke HoberechtiD, Millicent G. Hedditch, Lauren Whelan, Geraldine Healey, Dan Fayle, Kieran LauiD, Margaret A. PottsiD, Moore Z. CheniD, Angus P. R. JohnstoniD, Yang LiaoiD, Wei ShiiD, Andrew J. KuehiD, Benjamin HaleyiD, Jean‐Philippe FortiniD, Marco J. HeroldiD
Abstract
Cas12a is a gene-editing tool that simplifies multiplexed gene targeting through its RNase activity, enabling maturation of individual crRNAs from a pre-crRNA-encoding RNA. Here, we present a mouse model that constitutively expresses enhanced Acidaminococcus sp. Cas12a (enAsCas12a) linked to an mCherry fluorescent reporter. We demonstrate efficient single and multiplexed gene-editing in cells from enAsCas12aKI mice. To test in vivo activity, we transduced haematopoietic stem cells from E-MycT/+;enAsCas12aKI/+animals with Trp53-targeting pre-crRNAs followed by transplantation into irradiated recipient animals. Tumour development was accelerated and TRP53 protein lost. We generated compact, genome-wide Cas12a knockout libraries targeting each gene with four guide RNAs encoded on two (Menuetto) or one (Scherzo) vector. Introducing these libraries into E-MycT/+;enAsCas12aKI/+lymphoma cells followed by treatment with an MCL-1 inhibitor (S63845) or TRP53-inducer (nutlin-3a) identified known and novel drug resistance genes. Finally, we demonstrate simultaneous gene knockouts (Trp53 or combined Bax/Bak) and activation (Cd19) in primary T cells and mouse dermal fibroblasts from crosses of our enAsCas12a and CRISPR activation models (dCas9a-SAM). Our enAsCas12a mouse model and accompanying libraries enhance genome engineering capabilities and complements current CRISPR technologies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 1.20
- Field percentile
- top 26%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Efficient and multiplexed somatic genome editing with Cas12a mice
Jess D. Hebert, Haiqing Xu, … Monte M. Winslow·Nature Biomedical EngineeringPeer-reviewed·May 30, 2025
- High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogenetics
Kaiyuan Tang, Xiaoyu Zhou, … Sidi Chen·bioRxiv·Mar 14, 2024
- Improved Genome Editing by an Engineered CRISPR-Cas12a
E. Ma, K. Chen, … J. A. Doudna·bioRxiv·Sep 2, 2022
- Characterization and engineering of highly efficient Cas12j genome editors
Gundra Sivakrishna Rao, Wenjun Jiang, … Magdy M. Mahfouz·bioRxiv·Sep 16, 2025
- Efficient multiplex genome editing using CRISPR-Mb3Cas12a in mice
Zhuqing Wang, Yue Wang, … Wei Yan·bioRxiv·Aug 10, 2019
- Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineering
Matthew B. Dong, Kaiyuan Tang, … Sidi Chen·bioRxiv·Mar 14, 2023